Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-07 · accession 0001801170-24-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-09 | 2024-01-07 | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | F - Tax | $0.95 | -16.4K | 2.49M | -0.7% | -$15.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-01-07 | F | D | 16,369 | $0.95 | 2,485,771 | D | — | — | (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, and timely reported on a Form 4 filed on July 20, 2021. The remaining RSUs will vest on January 7, 2025, subject to the continued service of the Reporting Person on such date. |